December 15, 2022
VIA EDGAR
Ada D. Sarmento
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Verrica Pharmaceuticals Inc. |
Registration Statement on Form S-3 (File No. 333-268229)
Request for Acceleration of Effective Date
Acceleration Request
Requested Date: Monday, December 19, 2022
Requested Time: 8:00 a.m. Eastern Time
Dear Ms. Sarmento:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the Registrant) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-268229) (the Registration Statement) to become effective on December 19, 2022, at 8:00 a.m. Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Mark Ballantyne of Cooley LLP, counsel to the Registrant, at (703) 456-8084, or in his absence, Andrew Durand at (202) 776-2069.
Very truly yours, | ||
Verrica Pharmaceuticals Inc. | ||
By: | /s/ P. Terence Kohler Jr. | |
P. Terence Kohler Jr. | ||
Chief Financial Officer |